Lentiviral vectors: Their molecular design, safety, and use in laboratory and preclinical research

Human Gene Therapy

Volumn 22, Issue 6, 2011, Pages 649-657

  Dropulić, Boro ^a  

^a Lentigen Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

ARTICLE; CLINICAL RESEARCH; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE TRANSFER; GENOTOXICITY; HUMAN; IN VIVO STUDY; LABORATORY; NONHUMAN; STEM CELL RESEARCH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOMEDICAL RESEARCH; GENE THERAPY; GENETIC VECTORS; HIV-1; HUMANS; LENTIVIRUS; MICE; STEM CELL RESEARCH;

ANIMALIA; MAMMALIA;

EID: 79958211842     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.058     Document Type: Article

References (118)

1. Adachi, A., Gendelman, H.E., Koenig, S., et al. (1986). Production of acquired immunodeficiency syndrome-associated retrovi-rus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291. (Pubitemid 16013975)
2. Ali, N., Karlsson, C., Aspling, M., et al. (2009). Forward RNAi screens in primary human hematopoietic stem/progenitor cells. Blood 113, 3690-3695.
3. Anokye-Danso, F., Trivedi, C.M., Johr, D., et al. (2011). Highly efficient miRNA mediated reprogramming ofmouse and human somatic cells to pluripotency. Cell Stem Cell 8, 378-388.
4. Baltimore, D., Verma, I.M., Drost, S., and Mason, W.S. (1974). Temperature-sensitive DNA polymerase from Rous sarcoma virus mutants. Cancer 34(Suppl. 4), 1395-1397.
5. Brambrink, T., Foreman, R., Welstead, G.G., et al. (2008). Sequential expression of pluripotency markers during direct re-programming of mouse somatic cells. Cell Stem Cell 2, 151-159. (Pubitemid 351168714)
6. Brown, B.D., and Naldini, L. (2009). Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10, 578-585.
7. Brown, B.D., Venneri, M.A., Zingale, A., et al. (2006). Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12, 585-591.
8. Brown, B.D., Cantore, A., Annoni, A., et al. (2007). A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110, 4144-4152. (Pubitemid 351377775)
9. Buchholz, C.J., and Cichutek, K. (2006). Is it going to be SIN?: A European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: Initiative on hold. J. Gene Med. 8, 1274-1276. (Pubitemid 44660526)
10. Bukrinsky,M.(2004).Ahard way tothe nucleus. Mol. Med. 10, 1-5.
11. Bukrinsky, M.I., Haggerly, S., Dempsey, M.P., et al. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669. (Pubitemid 23350541)
12. Bulliard, Y., Wiznerowicz, M., Barde, I., and Trono, D. (2006). KRAB can repress lentivirus proviral transcription independently of integration site. J. Biol. Chem. 281, 35742-35746. (Pubitemid 46041304)
13. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C.C., et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818-823.
14. Cattoglio, C., Maruggi, G., Bartholomae, C., et al. (2010). High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. PLoS One 5, e15688.
15. Cavazzana-Calvo, M., Payen, E., Negre, O., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia. Nature 467, 318-322.
16. Cavazzana-Calvo, M., Fischer, A., Bushman, F.D., et al. (2011). Is normal hematopoiesis maintained solely by long-term multi-potent stem cells? Blood 117, 4420-4424.
17. Chang, L.J., and Zaiss, A.K. (2003). Self-inactivating lentiviral vectors and a sensitive Cre-loxP reporter system. Methods Mol. Med. 76, 367-382.
18. Chang, C.W., Lai, Y.S., Pawlik, K.M., et al. (2009). Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27, 1042-1049.
19. Chilov, D., Fux, C., Joch, H., and Fussenegger, M. (2003). Identification of a novel proliferation-inducing determinant using lentiviral expression cloning. Nucleic Acids Res. 31, e113.
20. Cornetta, K., Yao, J., Jasti, A., et al. (2011). Replication-competent lentivirus analysis of clinical grade vector products. Mol. Ther. 19, 557-566.
21. Dardalhon, V., Herpers, B., Noraz, N., et al. (2001). Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8, 190-198. (Pubitemid 32186130)
22. Davis, B.M., Humeau, L., Slepushkin, V., et al. (2004). ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells. Blood 104, 364-373. (Pubitemid 38900016)
23. D'Costa, J., Brown, H., Kundra, P., et al. (2001). Human immunodeficiency virus type 2 lentiviral vectors: Packaging signal and splice donor in expression and encapsidation. J. Gen. Virol. 82, 425-434. (Pubitemid 32123896)
24. De, A., Lewis, X.Z., and Gambhir, S.S. (2003). Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol. Ther. 7, 681-691. (Pubitemid 36626248)
25. De, R.J., Van, M.B., and Debyser, Z. (2005). Positional effects of the central DNA flap in HIV-1-derived lentiviral vectors. Biochem. Biophys. Res. Commun. 328, 987-994. (Pubitemid 40238733)
26. Desrosiers, R.C., Lifson, J.D., Gibbs, J.S., et al. (1998). Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72, 1431-1437. (Pubitemid 28116930)
27. Dropulić, B. (2001). Lentivirus in the clinic. Mol. Ther. 4, 511-512.
28. Dull, T., Zufferey, R., Kelly, M., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471. (Pubitemid 28471781)
29. Dupuy, F.P., Mouly, E., Mesel-Lemoine, M., et al. (2005). Lenti-viral transduction of human hematopoietic cells by HIV-1-and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. J. Gene Med. 7, 1158-1171. (Pubitemid 41335169)
30. Emi, N., Friedmann, T., and Yee, J.K. (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65, 1202-1207.
31. Esposito, D., and Craigie, R. (1999). HIV integrase structure and function. Adv. Virus Res. 52, 319-333.
32. Gilbert, J.R., and Wong-Staal, F. (2001). HIV-2 and SIV vector systems. Somat. Cell Mol. Genet. 26, 83-98. (Pubitemid 35332980)
33. Gordon, J.W., Scangos, G.A., Plotkin, D.J., et al. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. U.S.A. 77, 7380-7384. (Pubitemid 11131133)
34. Grandchamp, N., Henriot, D., Philippe, S., et al. (2011). Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors. Genet. Vaccines Ther. 9, 1.
35. Guryanova, O.A., Makhanov, M., Chenchik, A.A., et al. (2006). Optimization of a genome-wide disordered lentivector-based short hairpin RNA library. Mol. Biol. 40, 396-405. (Pubitemid 44264843)
36. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419. (Pubitemid 37296260)
37. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest 118, 3132-3142.
38. Hanawa, H., Yamamoto, M., Zhao, H., et al. (2009). Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken b-globin locus HS4 insulator element. Mol. Ther. 17, 667-674.
39. Herold, M.J., van den Brandt, J., Seibler, J., and Reichardt, H.M. (2008). Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. U.S.A. 105, 18507-18512.
40. Hockemeyer, D., Soldner, F., Cook, E.G., et al. (2008). A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3, 346-353.
41. Hofmann, A., Kessler, B., Ewerling, S., et al. (2003). Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 4, 1054-1060. (Pubitemid 37527423)
42. Jacobs, P.P., and Callewaert, N. (2009). N-Glycosylation engineering of biopharmaceutical expression systems. Curr. Mol. Med. 9, 774-800.
43. Jakobsen, M., Stenderup, K., Rosada, C., et al. (2009). Amelioration of psoriasis by anti-TNF-a RNAi in the xenograft transplantation model. Mol. Ther. 17, 1743-1753.
44. Jang, S.J., Kang, J.H., Kim, K.I., et al. (2010). Application of bio-luminescence imaging to therapeutic intervention of herpes simplex virus type I-thymidine kinase/ganciclovir in glioma. Cancer Lett. 297, 84-90.
45. Joshi, S., and Joshi, R.L. (1996). Molecular biology of human immunodeficiency virus type-1. Transfus. Sci. 17, 351-378.
46. Kafri, T., van Praag, H., Gage, F.H., and Verma, I.M. (2000). Len-tiviral vectors: Regulated gene expression. Mol. Ther. 1, 516-521.
47. Kawano, Y., Yoshida, T., Hieda, K., et al. (2004). A lentiviral cDNA library employing lambda recombination used to clone an inhibitor of human immunodeficiency virus type 1-induced cell death. J. Virol. 78, 11352-11359. (Pubitemid 39299676)
48. Kim, V.N., Mitrophanous, K., Kingsman, S.M., and Kingsman, A.J. (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72, 811-816. (Pubitemid 28048905)
49. Kingsman, S.M., Mitrophanous, K., and Olsen, J.C. (2005). Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther. 12, 3-4. (Pubitemid 40090038)
50. Kuhn, R., and Torres, R.M. (2002). Cre/loxP recombination system and gene targeting. Methods Mol. Biol. 180, 175-204.
51. Kurita, R., Oikawa, T., Okada, M., et al. (2008). Construction of a high-performance human fetal liver-derived lentiviral cDNA library. Mol. Cell. Biochem. 319, 181-187.
52. Kvell, K., Czompoly, T., Hiripi, L., et al. (2010). Characterisation of eGFP-transgenic BALB/c mouse strain established by len-tiviral transgenesis. Transgenic Res. 19, 105-112.
53. Laurenti, E., Barde, I., Verp, S., et al. (2010). Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo. Stem Cells 28, 1390-1398.
54. Levine, B.L., Humeau, L.M., Boyer, J., et al. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 103, 17372-17377. (Pubitemid 44788976)
55. Levy, L., Neuveut, C., Renard, C.A., et al. (2002). Transcriptional activation of interleukin-8 by b-catenin-Tcf4. J. Biol. Chem. 277, 42386-42393.
56. Li, M.J., and Rossi, J.J. (2005). Lentiviral vector delivery of re-combinant small interfering RNA expression cassettes. Methods Enzymol. 392, 218-226. (Pubitemid 40092517)
57. Lian, Q., Chow, Y., Esteban, M.A., et al. (2010). Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases. Thromb. Hae-most. 104, 39-44.
58. Lin, Y., Cheung, P., Roth, J.C., et al. (2011). Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells. Mol. Ther. (in press).
59. Lu, X., Humeau, L., Slepushkin, V., et al. (2004). Safe two-plasmid production for the first clinical lentivirus vector that achieves>99% transduction in primary cells using a one-step protocol. J. Gene Med. 6, 963-973. (Pubitemid 40228111)
60. Maetzig, T., Brugman, M.H., Bartels, S., et al. (2011). Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells. Blood 117, 3053-3064.
61. Maherali, N., Ahfeldt, T., Rigamonti, A., et al. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340-345.
62. Mangeot, P.E., Negre, D., Dubois, B., et al. (2000). Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J. Virol. 74, 8307-8315. (Pubitemid 30666680)
63. Manilla, P., Rebello, T., Afable, C., et al. (2005). Regulatory considerations for novel gene therapy products: A review of the process leading to the first clinical lentiviral vector. Hum. Gene Ther. 16, 17-25. (Pubitemid 40250328)
64. Maruggi, G., Porcellini, S., Facchini, G., et al. (2009). Transcrip-tional enhancers induce insertional gene deregulation independently from the vector type and design. Mol. Ther. 17, 851-856.
65. Marumoto, T., Tashiro, A., Friedmann-Morvinski, D., et al. (2009). Development of a novel mouse glioma model using lentiviral vectors. Nat. Med. 15, 110-116.
66. Mitrophanous, K., Yoon, S., Rohl, J., et al. (1999). Stable Gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6, 1808-1818. (Pubitemid 29531276)
67. Modlich, U., and Baum, C. (2009). Preventing and exploiting the oncogenic potential of integrating gene vectors. J. Clin. Invest. 119, 755-758.
68. Modlich, U., Navarro, S., Zychlinski, D., et al. (2009). Insertional transformation of hematopoietic cells by self-inactivating len-tiviral and gammaretroviral vectors. Mol. Ther. 17, 1919-1928.
69. Moffat, J., Grueneberg, D.A., Yang, X., et al. (2006). A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298.
70. Montini, E., Cesana, D., Schmidt, M., et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24, 687-696. (Pubitemid 43882120)
71. Montini, E., Cesana, D., Schmidt, M., et al. (2009). The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest 119, 964-975.
72. Montserrat, N., Garreta, B.E., Gonzalez, F., et al. (2011). Simple generation of human induced pluripotent stem cells using poly(b-amino esters) as non-viral gene delivery system. J. Biol. Chem. 286, 12417-12428.
73. Naldini, L. (1998). Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457-463. (Pubitemid 28478965)
74. Naldini, L., Blomer, U., Gallay, P., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. (Pubitemid 26119138)
75. Neschadim, A., McCart, J.A., Keating, A., and Medin, J.A. (2007). A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 13, 1407-1416. (Pubitemid 350091394)
76. Newrzela, S., Cornils, K., Li, Z., et al. (2008). Resistance of mature T cells to oncogene transformation. Blood 112, 2278-2286.
77. Nielsen, N.J., Pedersen, F.S., and Kjems, J. (2005). Molecular strategy to inhibit HIV-1 replication. Retrovirology 2, 10.
78. Niemann, H., and Kues, W.A. (2007). Transgenic farm animals: An update. Reprod. Fertil. Dev. 19, 762-770. (Pubitemid 47206973)
79. Niemann, H., Kues, W., and Carnwath, J.W. (2005). Transgenic farm animals: Present and future. Rev. Sci. Tech. 24, 285-298. (Pubitemid 41112547)
80. O'Brien, W.A., Zack, J.A., and Chen, I.S. (1990). Molecular pathogenesis of HIV-1. AIDS 4(Suppl. 1), S41-S48.
81. Parolin, C., Dorfman, T., Palu, G., et al. (1994). Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68, 3888-3895. (Pubitemid 24177414)
82. Patel, M., and Yang, S. (2010). Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev. 6, 367-380.
83. Pfeifer, A., and Hofmann, A. (2009). Lentiviral transgenesis. Methods Mol. Biol. 530, 391-405.
84. Pfeifer, A., Kessler, T., Yang, M., et al. (2001). Transduction of liver cells by lentiviral vectors: Analysis in living animals by fluorescence imaging. Mol. Ther. 3, 319-322. (Pubitemid 32514647)
85. Pluck, A. (1996). Conditional mutagenesis in mice: The Cre/loxP recombination system. Int. J. Exp. Pathol. 77, 269-278. (Pubitemid 27141644)
86. Pluta, K., and Kacprzak, M.M. (2009). Use of HIV as a gene transfer vector. Acta Biochim. Pol. 56, 531-595.
87. Pluta, K., Diehl, W., Zhang, X.Y., et al. (2007). Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: A comparative study. BMC Biotechnol. 7, 41.
88. Poeschla, E.M., Wong-Staal, F., and Looney, D.J. (1998). Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357. (Pubitemid 28144098)
89. Pomper, M.G., Hammond, H., Yu, X., et al. (2009). Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models. Cell Res. 19, 370-379.
90. Poznansky, M., Lever, A., Bergeron, L., et al. (1991). Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65, 532-536.
91. Punzon, I., Criado, L.M., Serrano, A., et al. (2004). Highly efficient lentiviral-mediated human cytokine transgenesis on the NOD/scid background. Blood 103, 580-582. (Pubitemid 38140089)
92. Rabson, A.B., and Martin, M.A. (1985). Molecular organization of the AIDS retrovirus. Cell 40, 477-480.
93. Ratner, L., Fisher, A., Jagodzinski, L.L., et al. (1987). Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses 3, 57-69. (Pubitemid 17144024)
94. Ray, P., De, A., Min, J.J., et al. (2004). Imaging tri-fusion multi-modality reporter gene expression in living subjects. Cancer Res. 64, 1323-1330.
95. Reichenbach, M., Lim, T., Reichenbach, H.D., et al. (2010). Germ-line transmission of lentiviral PGK-EGFP integrants in trans-genic cattle: New perspectives for experimental embryology. Transgenic Res. 19, 549-556.
96. Root, D.E., Hacohen, N., Hahn, W.C., et al. (2006). Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods 3, 715-719. (Pubitemid 44275739)
97. Salmon P., and Trono D. (2007). Production and titration of lentiviral vectors. Curr. Protoc. Hum. Genet. July, Chapter 12, Unit 12.10
98. Sander, W.E., Metzger, M.E., Morizono, K., et al. (2006). Non-invasive molecular imaging to detect transgene expression of lentiviral vector in nonhuman primates. J. Nucl. Med. 47, 1212-1219. (Pubitemid 47544918)
99. Shtutman, M., Maliyekkel, A., Shao, Y., et al. (2010). Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. Proc. Natl. Acad. Sci. U.S.A. 107, 7377-7382.
100. Singer, O., and Verma, I.M. (2008). Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr. Gene Ther. 8, 483-488.
101. Smolen, G.A., Zhang, J., Zubrowski, M.J., et al. (2010). A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev. 24, 2654-2665.
102. Soda, Y., Marumoto, T., Friedmann-Morvinski, D., et al. (2011). Feature article: Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 108, 4274-4280.
103. Sommer, C.A., Stadtfeld, M., Murphy, G.J., et al. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543-549.
104. Spencer, H.T., Denning, G., Gautney, R.E., et al. (2010). Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII. Mol. Ther. 19, 302-309.
105. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
106. Tarantal, A.F., Lee, C.C., Jimenez, D.F., and Cherry, S.R. (2006). Fetal gene transfer using lentiviral vectors: In vivo detection of gene expression by microPET and optical imaging in fetal and infant monkeys. Hum. Gene Ther. 17, 1254-1261. (Pubitemid 44975141)
107. Uchida, N., Washington, K.N., Lap, C.J., et al. (2011). Chicken HS4 insulators have minimal barrier function among progeny of human hematopoietic cells transduced with an HIV1-based lentiviral vector. Mol. Ther. 19, 133-139.
108. Vendel, A.C., and Lumb, K.J. (2003). Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat. Biochemistry 42, 910-916. (Pubitemid 36159522)
109. Warlich, E., Kuehle, J., Cantz, T., et al. (2011). Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol. Ther. 19, 782-789.
110. Welstead, G.G., Brambrink, T., and Jaenisch, R. (2008). Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4. J. Vis. Exp. 14, 734.
111. Wiederschain, D., Wee, S., Chen, L., et al. (2009). Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8, 498-504.
112. Wiznerowicz, M., and Trono, D. (2005). Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol. 23, 42-47. (Pubitemid 40075525)
113. Wu, J.C., Spin, J.M., Cao, F., et al. (2006). Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol, Genomics 25, 29-38.
114. Yee, J.K., Friedmann, T., and Burns, J.C. (1994). Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43(Pt A), 99-112.
115. Yu, S.F., vonRü den, T., Kantoff, P.W., et al. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 83, 3194-3198. (Pubitemid 16043003)
116. Zanta-Boussif, M.A., Charrier, S., Brice-Ouzet, A., et al. (2009). Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: Application to the gene therapy of WAS. Gene Ther. 16, 605-619.
117. Zennou, V., Serguera, C., Sarkis, C., et al. (2001). The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450. (Pubitemid 32428287)
118. Zufferey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retro-viral vectors. J. Virol. 73, 2886-2892. (Pubitemid 29135675)